iSpecimen (ISPC) vs XWELL (XWEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
XWELL is the larger company by market cap ($7.9 million vs $2.7 million), about 2.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ISPC | XWEL |
|---|---|---|
| Share price | $1.09 | $0.9189 |
| Market cap | $2.75M | $7.89M |
| 1-day change | -0.91% | +1.87% |
| EPS (TTM) | $-52.98 | $-5.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $37.60 | $2.20 |
| 52-week low | $1.02 | $0.26 |
| Distance from 52-week high | -97.10% | -58.23% |
| Average volume | 667.50K | 36.45K |
| Shares outstanding | 2.52M | 8.59M |
| Employees | 7 | 175 |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics & Research | Diagnostics & Research |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- XWELL is about 2.9 times larger than iSpecimen by market value ($7.89M vs $2.75M).
About iSpecimen
ISPC stock →iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Healthcare · Diagnostics & Research · 7 employees
About XWELL
XWEL stock →XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally.
Healthcare · Diagnostics & Research · 175 employees
ISPC vs XWEL FAQ
Which is bigger, iSpecimen or XWELL?
XWELL (XWEL) is larger, with a market capitalization of $7.89M compared with $2.75M for iSpecimen (ISPC).
Are iSpecimen and XWELL in the same industry?
Yes. Both are classified in the Diagnostics & Research industry within the Healthcare sector.